Radiomics and radiogenomics in ovarian cancer: a literature review

被引：50
作者：
Nougaret, S. [1 ,2 ]
McCague, Cathal [3 ]
Tibermacine, Hichem [1 ,2 ]
Vargas, Hebert Alberto [4 ]
Rizzo, Stefania [5 ,6 ]
Sala, E. [3 ]
机构：
[1] Univ Montpellier, Montpellier Canc Res Inst, IRCM, INSERM,U1194, 208 Ave Apothicaires, F-34295 Montpellier, France
[2] Montpellier Canc Inst, Dept Radiol, 208 Ave Apothicaires, F-34295 Montpellier, France
[3] Cambridge Biomed Campus, Dept Radiol, Box 218, Cambridge CB2 0QQ, England
[4] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA
[5] Ente Osped Cantonale EOC, Ist Imaging Svizzera Italiana IIMSI, Via Tesserete 46, CH-6900 Lugano, Switzerland
[6] Univ Svizzera Italiana, Fac Sci Biomed, Lugano, Switzerland
来源：
ABDOMINAL RADIOLOGY | 2021年 / 46卷 / 06期
关键词：
Ovarian cancer; Radiomics; Proteomics; Radiogenomics; ADNEXAL MASSES; ASYMPTOMATIC OVARIAN; MOLECULAR-PHENOTYPES; TEXTURE ANALYSIS; BREAST-CANCER; CT; TUMOR; HETEROGENEITY; IMAGES; RECURRENCE;
D O I：
10.1007/s00261-020-02820-z
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Ovarian cancer remains one of the most lethal gynecological cancers in the world despite extensive progress in the areas of chemotherapy and surgery. Many studies have postulated that this is because of the profound heterogeneity that underpins response to therapy and prognosis. Standard imaging evaluation using CT or MRI does not take into account this tumoral heterogeneity especially in advanced stages with peritoneal carcinomatosis. As such, newly emergent fields in the assessment of tumor heterogeneity have been proposed using radiomics to evaluate the whole tumor burden heterogeneity as opposed to single biopsy sampling. This review provides an overview of radiomics, radiogenomics, and proteomics and examines the use of these newly emergent fields in assessing tumor heterogeneity and its implications in ovarian cancer.
引用
收藏
页码：2308 / 2322
页数：15
相关论文
共 126 条
  • [51] Management of Asymptomatic Ovarian and Other Adnexal Cysts Imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement
    Levine, Deborah
    Brown, Douglas L.
    Andreotti, Rochelle F.
    Benacerraf, Beryl
    Benson, Carol B.
    Brewster, Wendy R.
    Coleman, Beverly
    DePriest, Paul
    Doubilet, Peter M.
    Goldstein, Steven R.
    Hamper, Ulrike M.
    Hecht, Jonathan L.
    Horrow, Mindy
    Hur, Hye-Chun
    Marnach, Mary
    Patel, Maitray D.
    Platt, Lawrence D.
    Puscheck, Elizabeth
    Smith-Bindman, Rebecca
    [J]. RADIOLOGY, 2010, 256 (03) : 943 - 954
  • [52] Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer
    Li, Miaomiao
    Tan, Jing
    Zhang, Ya
    Ai, Conghui
    Wang, Hongbo
    Zhang, Huimei
    Jin, Yan
    Chen, Yizhou
    [J]. ABDOMINAL RADIOLOGY, 2021, 46 (06) : 2367 - 2375
  • [53] An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
    Liu, Jianfang
    Lichtenberg, Tara
    Hoadley, Katherine A.
    Poisson, Laila M.
    Lazar, Alexander J.
    Cherniack, Andrew D.
    Kovatich, Albert J.
    Benz, Christopher C.
    Levine, Douglas A.
    Lee, Adrian V.
    Omberg, Larsson
    Wolf, Denise M.
    Shriver, Craig D.
    Thorsson, Vesteinn
    Hu, Hai
    [J]. CELL, 2018, 173 (02) : 400 - +
  • [54] Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT
    Low, RN
    Barone, RM
    Lacey, C
    Sigeti, JS
    Alzate, GD
    Sebrechts, CP
    [J]. RADIOLOGY, 1997, 204 (02) : 513 - 520
  • [55] Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT, with subsequent surgical correlation
    Low, RN
    Semelka, RC
    Worawattanakul, S
    Alzate, GD
    Sigeti, JS
    [J]. RADIOLOGY, 1999, 210 (03) : 625 - 632
  • [56] A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer
    Lu, Haonan
    Arshad, Mubarik
    Thornton, Andrew
    Avesani, Giacomo
    Cunnea, Paula
    Curry, Ed
    Kanavati, Fahdi
    Liang, Jack
    Nixon, Katherine
    Williams, Sophie T.
    Hassan, Mona Ali
    Bowtell, David D. L.
    Gabra, Hani
    Fotopoulou, Christina
    Rockall, Andrea
    Aboagye, Eric O.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [57] Reflections on radiogenomics and oncologic radiomics
    Lubner, Meghan G.
    [J]. ABDOMINAL RADIOLOGY, 2019, 44 (06) : 1959 - 1959
  • [58] CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges
    Lubner, Meghan G.
    Smith, Andrew D.
    Sandrasegaran, Kumar
    Sahani, Dushyant V.
    Pickhardt, Perry J.
    [J]. RADIOGRAPHICS, 2017, 37 (05) : 1483 - U304
  • [59] TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
    Mandilaras, Victoria
    Garg, Swati
    Cabanero, Michael
    Tan, Qian
    Pastrello, Chiara
    Burnier, Julia
    Karakasis, Katherine
    Wang, Lisa
    Dhani, Neesha C.
    Butler, Marcus O.
    Bedard, Philippe L.
    Siu, Lillian L.
    Clarke, Blaise
    Shaw, Patricia Ann
    Stockley, Tracy
    Jurisica, Igor
    Oza, Amit M.
    Lheureux, Stephanie
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 346 - 352
  • [60] Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases
    Masoodi, Tariq
    Siraj, Sarah
    Siraj, Abdul K.
    Azam, Saud
    Qadri, Zeeshan
    Parvathareddy, Sandeep K.
    Tulbah, Asma
    Al-Dayel, Fouad
    AlHusaini, Hamed
    AlOmar, Osama
    Al-Badawi, Ismail A.
    Alkuraya, Fowzan S.
    Al-Kuraya, Khawla S.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (08) : 1219 - 1230
12345678910